|
You are here |
brighterworld.mcmaster.ca | ||
| | | | |
www.cancer.gov
|
|
| | | | | The success of COVID-19 mRNA vaccines could accelerate research on mRNA vaccines to treat cancer. Read about the progress of mRNA cancer vaccines. | |
| | | | |
www.the-scientist.com
|
|
| | | | | Adenovirus vectors deliver the genetic instructions for SARS-CoV-2 antigens directly into patients' cells, provoking a robust immune response. But will pre-existing immunity from common colds take them down? | |
| | | | |
www.fda.gov
|
|
| | | | | The FDA amended the emergency use authorization of the Novavax COVID-19 Vaccine, Adjuvanted for use in individuals 12 years of age and older to include the 2023-2024 formula. The updated vaccine addresses currently circulating variants to provide better protection against serious consequences of COV | |
| | | | |
notes.kateva.org
|
|
| | | A personal blog of diverse opinions. | ||